Claire Ryan, MD
Orthopaedic Trauma · Kyle, TXNPI 1346774163
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (47.2%), education and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Arthrex at 50.8% of the total. Reporting peaked in 2023 at $28,763 and has fallen 98.2% since, to $525 in 2025.
Across 74 payments — averaging $599.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$23K
- Smith+Nephew$13K
- Medinc Of Texas$5K
- Stryker$951
- DJO, LLC$938
- Core Surgical Group$869
- plus $507 from 9 others
What the payments were for
- Grants$20,93847%
- Travel & lodging$2,7086%
- Food & beverage$2,5446%
- Education$18,14841%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 28 | $22,502 |
| Smith+Nephew | 8 | $13,350 |
| Medinc Of Texas | 5 | $5,221 |
| Stryker | 14 | $951 |
| DJO, LLC | 1 | $938 |
| Core Surgical Group | 7 | $869 |
| Illuminoss Medical, Inc. | 1 | $138 |
| Johnson & Johnson | 2 | $130 |
| UCB, Inc. | 2 | $61 |
| Conetic Solutions, Inc. | 1 | $48 |
| Vericel Corporation | 1 | $44 |
| Si-bone, Inc. | 1 | $28 |
| Ossur Americas, Inc. | 1 | $21 |
| Bard Peripheral Vascular, Inc. | 1 | $20 |
| Bioventus LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FAST-FIX$360
- Firstpass$360
- ACUFEX Meniscal Root Repair$360
- ICONIX$281
- SALVATION$276
- Photodynamic Bone Stabilization Procedure Pack$138
- VA-LCP$102
How this compares
$44,338 in reported general payments places this provider in the 75th percentile of 74 orthopaedic trauma providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 20 | $578 |
| Oxycodone Hcl | 11 | $50 |
| Tramadol Hcl | 13 | $32 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic trauma in Kyle
- Cory CollingeFort Worth$2.8M
- John MunzHouston$1M
- Kyle DicksonHouston$975K
- Timothy AchorHouston$561K
- Jonathan EastmanHouston$361K
- Stephen WarnerHouston$357K
- Edgar AraizaDallas$270K
- Milton L RouttHouston$266K
- Andrew ChooHouston$262K
- Richard BarberCorpus Christi$244K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.